Blake E. Dewey, PhD


Expanding the Use of Spinal Cord Atrophy in Multiple Sclerosis: Blake E. Dewey, PhD

The postdoctoral researcher at the Johns Hopkins Multiple Sclerosis Center shared his perspective on the use of spinal cord atrophy in clinical practice to measure disease progression in MS and how it might become more accessible. [WATCH TIME: 4 minutes]

Theresa Sevilis, DO


Taking the Leap: Forging Your Own Path as a Woman in Medicine

Theresa Sevilis, DO, writes on picking a career path in medicine as a woman, and how deciding to jump ship from a traditional path was among the best decisions she's made.

Jacqueline Glascock, PhD


2022 SMA Research & Clinical Care Meeting: What to Expect

Mary Schroth, MD, and Jacqueline Glascock, PhD, of Cure SMA, share their perspectives on the upcoming annual meeting.

Anne H. Cross, MD


Future Directions in Research and Treatment

Looking to the future of multiple sclerosis care, the panel of thought leaders pose important questions that remain to be answered in the research and treatment of multiple sclerosis.

Kari Rosbeck


TSC Alliance’s Growth Has Led to Improved Lives and Progress Toward a Cure

In light of Tuberous Sclerosis Complex (TSC) Awareness Month throughout May, Kari Rosbeck, president and CEO, TSC Alliance, highlights what has been done to advance TSC research and how the organization is improving the diagnosis journey, access to care, and support for families.

Konstantin Karmazin, MD


Future Plans, Goals for Prime PD: Konstantin Karmazin, MD

The chief medical officer of Prime PD, a new digital wellness studio for patients with Parkinson disease, detailed future initiatives for the platform. [WATCH TIME: 4 minutes]

Christopher Elder, MD


Recommendations for Treating Epilepsy in the Clinical Space: Christopher Elder, MD

The clinical assistant professor of neurology in the Comprehensive Epilepsy Center at NYU Langone Health gives recommendations for clinical care on prescribed antiseizure medication and RNA therapy. [WATCH TIME: 5 minutes]

George Grossberg, MD


Raising Awareness of Neuropsychiatric Symptoms in Neurodegenerative Diseases: George Grossberg, MD

The director of Geriatric Psychiatry at the St Louis University School of Medicine discussed the need to improve awareness of the signs of psychiatric-related symptoms and to eliminate the stigmas associated with them. [WATCH TIME: 3 minutes]

David Vossler, MD


David Vossler, MD: Treating Generalized Tonic-Clonic Seizures

The Medical Director of The Neuroscience Institute at UW Medicine Valley Medical Center discussed the landscape of therapy for tonic-clonic seizures and how lacosamide might fit into the paradigm.

Lisanne Dommershuijsen, MSc


Takeaways From MDS 2021: Lisanne Dommershuijsen, MSc

Following her presentation at MDS 2021, the PhD candidate in epidemiology at Erasmus University Medical Center discussed highlights from this year’s virtual congress. [WATCH TIME: 2 minutes]

Andrea Synowiec, DO


Using a Headache Registry to Tailor Treatment Decisions, Long-Term Goals of Patients: Andrea Synowiec, DO

The assistant director of the Allegheny Headache Center provided insight on how the center utilizes its headache registry to construct treatment plans, along with identifying questions that still need answers. [WATCH TIME: 3 minutes]

Alvin Wang, DO, BC-EMS


The Benefits of Mobile Stroke Units: Alvin Wang, DO, BC-EMS

The chief of emergency medical services at Jefferson Health spoke about the operation of the Jefferson mobile stroke unit in the field, and the impact that the onset of the COVID-19 pandemic had on launching the program. [WATCH TIME: 3 minutes]

Jill Dehlin, RN


Treating Patients With Migraine

What physicians in the community need to know about treating patients with migraine in community settings, and resources that can help locate certified headache specialists or other migraine specialists for referral.

Evelyn Sbar, MD


Building Your Acute Migraine Toolbox

Plagued by a long history of under- and inadequate treatment, clinicians have more options than ever to craft a personalized, effective plan for their patients.

Jinsy A. Andrews, MD, MSc


Managing New Therapies for Neuromuscular Diseases: Jinsy Andrews, MD, MSc

The director of neuromuscular clinical trials at Columbia University Irving Medical Center shared her perspective on the challenges of familiarizing oneself with the influx of novel medications for neuromuscular diseases. [WATCH TIME: 3 minutes]

Bijan Nejadnik, MD


Stem Cell Therapy Studies in TBI and Stroke: Bijan Nejadnik, MD

The chief medical officer at SanBio discussed how the investigational agent SB623 is being studied in TBI and stroke, with future planned studies in Alzheimer disease.

Aristide Merola, MD, PhD


Advanced Parkinson Disease: Looking Ahead

Panelists look ahead in the management of advanced Parkinson disease and discuss the promise of different investigational therapies.

Masahito Kawabori, MD, PhD


Stem Cell Therapy for TBI: Masahito Kawabori, MD, PhD

The associate professor at Hokkaido University and investigator of STEMTRA also discussed other efforts in stroke, Alzheimer disease, and Parkinson disease.

Ilya Kister, MD


Greatest Recent Advancements in MS, Looking Toward the Future: Ilya Kister, MD

The professor of neurology at the NYU Grossman School of Medicine provided his thoughts on the most notable strides within the multiple sclerosis field in the past year. [WATCH TIME: 3 minutes]

Jay Alberts, PhD


Challenges With Assessing Stages of Parkinson Disease and the Lack of Standardized Biomarkers: Jay Alberts, PhD

The Edward F. and Barbara A. Bell Endowed Chair at Cleveland Clinic discussed the complexities with identifying viable biomarkers for Parkinson disease, as well as interventions geared toward specific regions of the brain. [WATCH TIME: 4 minutes]

Jan Brandes, MD, MS


Attracting More Women to Neurology: Jan Brandes, MD, MS

The assistant clinical professor at Vanderbilt University School of Medicine discussed ways of incorporating and encouraging women physicians to enter the neurology specialty. [WATCH TIME: 4 minutes]

Julienne Verdi


Planning for Headache on the Hill Through Community Outreach, Research: Julienne Verdi

The executive director of the Alliance for Headache Disorders Advocacy provided perspective on the preparation that goes into Headache on the Hill, and the parties involved in this process. [WATCH TIME: 5 minutes]

Susana Vacas, MD, PhD


Improving Surgery Communication, Risk Factor Assessment for Older Adults: Susana Vacas, MD, PhD

Following the publication of a recent article outlining the association of the use of anesthesia during surgery and cognitive decline in older adults, the assistant professor of anesthesiology at the David Geffen School of Medicine, UCLA, spoke on the need to assess risk factors. [WATCH TIME: 5 minutes]

James Beck, PhD


The Future of Genetic Approaches, New Targets in Parkinson Disease: James Beck, PhD

The senior vice president and chief scientific officer of the Parkinson’s Foundation discussed the potential for new therapies that target genetically mutated forms of Parkinson disease. [WATCH TIME: 3 minutes]

Pavel Klein, MD


Pavel Klein, MD: Determining Likelihood of Efficacy and AEs in Patient Populations

The director of the Mid-Atlantic Epilepsy and Sleep Center discussed his team’s investigations into predicting responders and adverse events.

Suma Shah, MD


The Ever-Expanding Multiple Sclerosis Therapeutics

Join Ahmed Obeidat, MD, PhD; Mitchell Freedman, MD; and Suma Shah, MD, for the second program of this monthly series as they discuss the evolution of therapeutics for the treatment of multiple sclerosis.

Heidi Crayton, MD


Key Points for the Management of Multiple Sclerosis

Stephen Krieger, MD; Daniel Bandari, MD, MS; Bruce Hughes, MD; Mitzi Williams, MD; and Heidi Crayton, MD, provide key takeaways for the treatment of patients with multiple sclerosis.

Donald S. Wood, PhD


The Expectations for the 2023 MDA Conference: Donald S. Wood, PhD; Sharon Hesterlee, PhD

The president and CEO, as well as the executive vice president and chief research officer, of MDA, together offered an in-depth overview of what to expect from the 2023 MDA Conference, which will be held from March 19-22, 2023, in Dallas, Texas. [WATCH TIME: 12 minutes]

Yanhong Shi, PhD


Potential for Alzheimer Drug Development With Miniature Brain Models: Yanhong Shi, PhD

The director of stem cell biology research at City of Hope spoke on the newly developed brain organoid, which has the potential to help investigators identify pathological mechanisms of Alzheimer disease.

© 2023 MJH Life Sciences

All rights reserved.